My watch list
my.chemeurope.com  
Login  

Norepinephrine reuptake inhibitor



  Norepinephrine reuptake inhibitors (NRIs), also known as noradrenaline reuptake inhibitors (NARIs), are compounds that elevate the extracellular level of the neurotransmitter norepinephrine in the central nervous system by inhibiting its reuptake from the synaptic cleft into the presynaptic neuronal terminal. The drugs inhibit the class of neurotransmitter transporters known as norepinephrine transporters. They have virtually no action at other monoamine transporters.

Additional recommended knowledge

List of NRIs

Strattera® is available in the United States and is indicated by the Food and Drug Administration (FDA) for the treatment of ADD and ADHD. Off-label uses include the treatment of depression and anxiety.

Reboxetine, unavailable in the United States and Canada, has been found to be effective at combating depression.

Radafaxine, a potent metabolite of Bupropion, is currently being developed by GlaxoSmithKline.

See also


 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Norepinephrine_reuptake_inhibitor". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE